These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16892334)

  • 1. 2-{3-[2-(4-chlorophenyl)ethoxy]phenylthio}-2-methylpropanoic acid: a fibrate-like compound with hypolipidemic and antidiabetic activity.
    Dell'Uomo N; Tassoni E; Brunetti T; Pessotto P; Sciarroni AF; Milazzo FM; De Angelis F; Peschechera A; Tinti MO; Carminati P; Giannessi F
    ChemMedChem; 2006 Jan; 1(1):49-53. PubMed ID: 16892334
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis, biological evaluation and molecular modeling studies of arylidene-thiazolidinediones with potential hypoglycemic and hypolipidemic activities.
    da Costa Leite LF; Veras Mourão RH; de Lima Mdo C; Galdino SL; Hernandes MZ; de Assis Rocha Neves F; Vidal S; Barbe J; da Rocha Pitta I
    Eur J Med Chem; 2007 Oct; 42(10):1263-71. PubMed ID: 17448573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different behavior toward racemization in basic media from chiral analogs of clofibric acid, the active metabolite of the antilipidemic drug clofibrate.
    Ferorelli S; Loiodice F; Longo A; Molfetta A; Tortorella V; Amoroso R
    Chirality; 2000 Nov; 12(10):697-704. PubMed ID: 11054827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology and mechanism of action of etofibrate].
    Schatton W
    Med Welt; 1982 Sep; 33(38):1310-4. PubMed ID: 6752630
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin-fibrate combination therapy.
    Feeman WE
    Am J Cardiol; 2008 May; 101(10):1521. PubMed ID: 18471475
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plafibride--is it an effective drug as a hypolipemic agent?].
    Joven J
    Med Clin (Barc); 1985 Apr; 84(15):632. PubMed ID: 3999857
    [No Abstract]   [Full Text] [Related]  

  • 7. [A double blind study of the new hypolipidemic agent pirozadil (722-D) using patients with ischemic heart disease (author's transl)].
    Cadierno Carpintero M; Emeterio Reig E; Soler Masana JM
    Med Clin (Barc); 1982 May; 78(9):386-9. PubMed ID: 7047927
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid therapy with etofibrate. Reduction of multiple risk factors with an active substance. Report of an international seminar. 8-11 November 1989, Houston, Texas].
    Fortschr Med Suppl; 1990; 85():1-15. PubMed ID: 2338325
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy of vascular insufficiency of the legs with plafibride].
    Lázaro Campillo T; Gesto Castromil R; de la Sierra L; Pujadas J; Villafana W; Moreno R
    Med Clin (Barc); 1984 Dec; 83(18):752-5. PubMed ID: 6521538
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of ischemic ulcers of the lower extremities using plafibride].
    Palou Monzo J; López-Delmás FJ
    Angiologia; 1984; 36(6):273-8. PubMed ID: 6517385
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrates inhibit aldose reductase activity in the forward and reverse reactions.
    Balendiran GK; Rajkumar B
    Biochem Pharmacol; 2005 Nov; 70(11):1653-63. PubMed ID: 16226225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acute rhabdomyolysis associated with digestive disorders during a voluntary overdose of ciprofibrate].
    Giraud O; Chanu B; Farge D; Parrot F; Brestescher C; Rouffy J
    Gastroenterol Clin Biol; 1995 Feb; 19(2):231-2. PubMed ID: 7750722
    [No Abstract]   [Full Text] [Related]  

  • 13. [What are the possibilities in the treatment of primary hyperlipidemia in diabetes mellitus?].
    Stratmann FW
    Med Welt; 1982 Apr; 33(17):651. PubMed ID: 7098830
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid.
    Ammazzalorso A; Amoroso R; Baraldi M; Bettoni G; Braghiroli D; De Filippis B; Giampietro L; Tricca ML; Vezzalini F
    Eur J Med Chem; 2005 Sep; 40(9):918-21. PubMed ID: 15950326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoglycemic polysaccharides from the tuberous root of Liriope spicata.
    Chen X; Liu Y; Bai X; Wen L; Fang J; Ye M; Chen J
    J Nat Prod; 2009 Nov; 72(11):1988-92. PubMed ID: 19874043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of novel dual functional agent as PPARgamma agonist and 11beta-HSD1 inhibitor for the treatment of diabetes.
    Ye YL; Zhou Z; Zou HJ; Shen Y; Xu TF; Tang J; Yin HZ; Chen ML; Leng Y; Shen JH
    Bioorg Med Chem; 2009 Aug; 17(15):5722-32. PubMed ID: 19574056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
    Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
    Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and hypolipidemic activity of novel 2-(naphthalen-2-yloxy)propionic acid derivatives as desmethyl fibrate analogs.
    Idrees GA; Aly OM; Abuo-Rahma Gel-D; Radwan MF
    Eur J Med Chem; 2009 Oct; 44(10):3973-80. PubMed ID: 19450906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the fibrate binding specificity of rat liver fatty acid binding protein.
    Chuang S; Velkov T; Horne J; Wielens J; Chalmers DK; Porter CJ; Scanlon MJ
    J Med Chem; 2009 Sep; 52(17):5344-55. PubMed ID: 19663428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular pharmacology and medicinal chemistry of fibrate].
    Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):108-12. PubMed ID: 17424995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.